Inflammatory Bowel Disease
The IBD Clinical Trials Team conducts clinical trials of new drugs for patients with inflammatory bowel diseases, including Crohn’s Disease, Ulcerative Colitis and related conditions.
AMETRINE-1 (A potential new treatment for UC)
A study on the safety & effectiveness of RO7790121 in the treatment of moderately to severely active UC
A potential new treatment for Eosinophilic Esophagitis (EoE)
A potential new treatment for ulcerative colitis (ATLAS-UC)
A new treatment for Eosinophilic Esophagitis
A study of the safety and effectiveness of tezepelumab in adolescent and adult participants with Eosinophilic Esophagitis
FUZION: Efficacy and safety of guselkumab in participants with fistulizing, perianal Crohn’s Disease
FUZION: Efficacy and safety of guselkumab in participants with fistulizing, perianal Crohn’s Disease
An oral treatment for Ulcerative Colitis
Study of GS-5290 in participants with moderately to severely active ulcerative colitis
Evaluating a new treatment for paediatric patients with ulcerative colitis.
The purpose of this study is to evaluate the effectiveness of guselkumab in pediatric participants with moderately to severely active ulcerative colitis through open label induction and through maintenance therapy among participants who were induction responders.
Healing and Disease-Modifying Effect of Guselkumab in Crohn’s Disease Patients
Testing a new treatment for people with Crohn's Disease
A Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis (SWIFT)